Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan

Clicks: 229
ID: 272946
2002
Resistance among uropathogenic Escherichia coli to trimethoprim-sulfamethoxazole (TMP-SMX) has increased. Risk factors for resistance and the impact on clinical failure have been poorly described. We performed a retrospective cohort study of women with acute uncomplicated cystitis seen at a universi …
Reference Key
pd2002clinicalprevalence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Brown PD;Freeman A;Foxman B;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2002
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11914994
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't adult female adolescent aged middle aged risk factors Retrospective Studies Bacterial drug resistance Cohort Studies escherichia coli / isolation & purification drug combinations anti-infective agents urinary / pharmacology* urinary tract infections / drug therapy urinary tract infections / microbiology* escherichia coli / drug effects* prevalence escherichia coli infections / microbiology* michigan / epidemiology sulfamethoxazole / therapeutic use trimethoprim / therapeutic use urinary tract infections / epidemiology escherichia coli infections / epidemiology pmid:11914994 doi:10.1086/339491 patricia d brown alison freeman betsy foxman urinary / therapeutic use escherichia coli infections / drug therapy sulfamethoxazole / pharmacology* trimethoprim / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.